Ifp Advisors, Inc Tiziana Life Sciences LTD Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$0.55 - $0.83 $658 - $994	1,198 Added 239.6%	1,698 $3,000
Q2 2022 Sep 06, 2022	BUY	$0.66 - $1.06 $330 - $530	500 New	500 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.06 $330 - $530	-500 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.62 - $1.25 $310 - $625	500 New	500 $0

1.03M

19.2K

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $91M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.